One event. Multiple sources.
Health

Stopping Ozempic may raise heart attack and stroke risk

1 publisher first detected 2% of 51 Health publishers

Headline as filed by ScienceDaily.

Compare coverage — 1 report

Every publisher that filed on this event, earliest first, with each one's headline, summary, times and how long after the first report they filed.
Publisher Headline Summary Published Detected Delay Source Status
ScienceDaily Stopping Ozempic may raise heart attack and stroke risk
A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medic
0m sciencedaily.com First

Headlines and summaries belong to the publisher named beside them. “Published” is what their feed stated; “detected” is when PageNews first held the report. Delay is measured from the earliest report on this event and describes timing only.

Reader comments

Comments are written by readers. PageNews does not check them and does not stand behind them, and a name here is a name someone typed, not a person we have identified.

Nobody has commented on this story yet.

Add a comment

Up to 2,000 characters. Links are not accepted. Blank lines separate paragraphs.

In this story
Ozempic 14 Wegovy 4 Mounjaro 3 Zepbound 3

Related coverage

connected by shared subjects